Key facts
- SFC Fluidics’s last known valuation is $31.0M (Aug 2022).
- It has raised $7.7M across 3 recorded rounds; the latest was Seed Round ($250K) in Oct 2025.
- Notable investors include US National Science Foundation, United States Department of War, Keiretsu Forum, National Aeronautics and Space Administration, Breakthrough T1D — 13 tracked in total.
- SFC Fluidics has filed 6 Form Ds with the SEC since 2011, most recently Jun 2023 ($55K sold to 2 investors).
- Status: Privately Held (backing).
Investors
13+- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for SFC Fluidics
Funding rounds
3 roundsAbout SFC Fluidics
Developer of a dual-hormone patch pump designed to advance healthcare and improve quality of life through microfluidic technologies. The company's pump can control the delivery of both insulin and glucagon in a discreet patch pump that is the same size as the insulin-only patch pumps, and the technology is also suitable for the delivery of other subcutaneous biologics, enabling diabetic patients to improve their lifestyle and avoid complications.
- Sector
- Healthcare
- HQ
- Fayetteville, AR, United States
- Founded
- 2003
- Employees
- 10
- Website
- sfc-fluidics.com/
- Ownership
- Privately Held (backing)
SFC Fluidics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in SFC Fluidics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on SFC Fluidics in its N-PORT filings yet. We sweep new filings monthly.